Gomes LEM, Silva FAR da, Pascoal LB, et al. Authors’ Reply – Comments: Serum levels of infliximab in Brazilian patients with Crohn’s disease: what are the reasons for differences from previous studies?. Clinics. 2019;74:e1517. doi:10.6061/clinics/2019/e1517